Document is current
Any future updates will be listed below
-
Authors
Kotzyba, Jeanne
Baux, Elisabeth
Hansmann, Yves
Boyer, Pierre
Jaulhac, Benoît
Martinot, Martin
Martha, Benoît
Kaeuffer, Charlotte
Bonijoly, Thomas
Bani-Sadr, Firouzé
Legoff, Antoine
Hoefler, Florence
Blot, Mathieu
Bourdellon, Loïc
Zilliox, Laurence
Boulanger, Nathalie
Lefevre, Benjamin
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05458245 at ClinicalTrials.govDocuments that mention this clinical trial
Tick-borne lymphadenopathy in northeastern France: a human and vector clinical–epidemiological study
https://doi.org/10.1186/s13071-025-07078-2
- License Information
-
More Information
Article History
Received: 17 May 2025
Accepted: 23 September 2025
First Online: 24 October 2025
Declarations
:
: This study complies with the principles outlined in the Declaration of Helsinki and its later amendments. This study was approved by the Nancy Hospital Ethics Committee (22 April 2022; decision no. 348). Patients received complete information about the study (ClinicalTrials.gov ID NCT05458245). In accordance with French law, patient consent was not needed. Nevertheless, patients could decline to participate.
: Not applicable.
: The authors declare no competing interests.
